CN106668864A - External-use ointment for treatment of dermatopathy - Google Patents
External-use ointment for treatment of dermatopathy Download PDFInfo
- Publication number
- CN106668864A CN106668864A CN201610907215.0A CN201610907215A CN106668864A CN 106668864 A CN106668864 A CN 106668864A CN 201610907215 A CN201610907215 A CN 201610907215A CN 106668864 A CN106668864 A CN 106668864A
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- chloramphenicol
- cream
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 36
- 238000011282 treatment Methods 0.000 title abstract description 23
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960005091 chloramphenicol Drugs 0.000 claims abstract description 18
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims abstract description 18
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- 229940116229 borneol Drugs 0.000 claims abstract description 10
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000004202 carbamide Substances 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960000282 metronidazole Drugs 0.000 claims abstract description 10
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960004618 prednisone Drugs 0.000 claims abstract description 10
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 claims abstract description 10
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960002117 triamcinolone acetonide Drugs 0.000 claims abstract description 10
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960003291 chlorphenamine Drugs 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 8
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims abstract description 7
- 229960004125 ketoconazole Drugs 0.000 claims abstract description 7
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims abstract description 7
- 229960000699 terbinafine hydrochloride Drugs 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000006071 cream Substances 0.000 claims description 22
- 235000013877 carbamide Nutrition 0.000 claims description 9
- 241000411851 herbal medicine Species 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 abstract description 14
- 208000010668 atopic eczema Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 7
- 208000003251 Pruritus Diseases 0.000 abstract description 7
- 208000017520 skin disease Diseases 0.000 abstract description 7
- 230000003266 anti-allergic effect Effects 0.000 abstract description 4
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 3
- 206010000496 acne Diseases 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 241000905957 Channa melasoma Species 0.000 abstract description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 abstract description 2
- 201000004681 Psoriasis Diseases 0.000 abstract description 2
- 210000001126 granulation tissue Anatomy 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000002757 inflammatory effect Effects 0.000 abstract description 2
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229940052810 complex b Drugs 0.000 abstract 1
- 235000013312 flour Nutrition 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 229960005404 sulfamethoxazole Drugs 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 201000004647 tinea pedis Diseases 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 201000009053 Neurodermatitis Diseases 0.000 description 4
- 208000002474 Tinea Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010048768 Dermatosis Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 206010012435 Dermatitis and eczema Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- 241000124033 Salix Species 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 241000238740 Dermatophagoides pteronyssinus Species 0.000 description 1
- 208000019872 Drug Eruptions Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002315 pressor effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 206010052366 systemic mycosis Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to an external-use ointment for treatment of dermatopathy. The ointment is prepared by mixing and blending the following medicines (by weight): 6-9 parts of sulfamethoxazole, 5-8 parts of chloramphenicol, 5-8 parts of prednisone, 3-5 parts of borneol, 0-8 parts of sulfur flour, 5-8 parts of vitamin E, 4-8 parts of vitamin complex B, 6-10 parts of VC, 5-7 parts of B1, 0.01-0.04 part of triamcinolone acetonide, 10 parts of urea ointment, 30 parts of a Chinese herbal antibacterial paste, 8-10 parts of chlorpheniramine, 4-8 parts of chloramphenicol raw powder, 6-10 parts of metronidazole, 10 parts of B6 ointment, 0-15 parts of terbinafine hydrochloride emulsifiable paste and 0-10 parts of ketoconazole emulsifiable paste. The ointment of the invention is used for treatment of skin diseases such as dermatitis, eczema, acne, yellow fluid ulcers, manus and tinea pedis, psoriasis, etc., can be used for realizing antibiosis, anti-inflammation, itching-relieving and antiallergic functions and the function of boosting body immunity, reduces exudation and inflammatory response and promotes inflammatory resorption of wounds and growth of granulation tissues, and has a good comprehensive treatment effect.
Description
Technical field
The present invention relates to Chinese patent drug, specifically one kind treat dermopathic external-applied ointment.
Background technology
Eczema, neurodermatitis are the high dermis and epidermal inflammation caused by various internal and external factors, and the cause of disease is complicated, typically
Think relevant with allergy, easy recurrent exerbation, clinically acute stage skin damaged have and ooze out tendency based on the sore rash of mound.It is internal because
Element:Chronic infection focus, endocrine and metabolism change, blood circulation disorder, psychoneural factor, inherent cause;External factor:
The generation of this disease can be by food(Such as fishes and shrimps, beef and mutton), inhalation (inhalatio)(Such as pollen, dermatophagoides pteronyssinus, microorganism), living environment(Such as
Daylight, sweltering heat, drying etc.), animal fur, various chemical substances etc. induce and increase.
The drug side-effect of the scytitises such as existing treatment eczema, neurodermatitis is larger, and effect is less obvious, holds
Easily recurrence, flow process is more, high cost.
The content of the invention
In view of the deficiencies in the prior art, the present invention provides one kind and can realize antibacterial, anti-inflammatory, antipruritic, antiallergy and enhancing
Body's immunity, reduction is oozed out and inflammatory reaction, promotes surface of a wound inflammatory to absorb and granulation tissue growth, reaches Synthetic curative effect
The dermopathic external-applied ointment for the treatment of of fruit.
The technical solution used in the present invention is:
One kind treats dermopathic external-applied ointment, counts by weight, by agents hybrid modulation into cream:Radonil 6-9 parts;
Chloramphenicol 5-8 parts;Prednisone 5-8 parts;Borneol 3-5 parts;Sofril 0-8 parts;Vitamin E 5-8 parts;The compound B 4-8 of vitamin
Part;VC 6-10 parts;B1 5-7 parts;Triamcinolone acetonide 0.01-0.04 parts;10 parts of carbamide ointment;Antibacterial 30 parts of the cream of book on Chinese herbal medicine;Chlorpheniramine
8-10 parts;Chloramphenicol original powder 4-8 parts;Metronidazole 6-10 parts;10 parts of B6 ointment;Terbinafine hydrochloride emulsifiable paste 0-15 parts;Ketoconazole
Emulsifiable paste 0-10 parts.
Further, by agents hybrid modulation into cream:Radonil 8g;Chloramphenicol 7g;Prednisone 5g;Borneol 4g;Sulphur
Bloom 5g;Vitamin E 5g;The compound B 8g of vitamin;VC 8g;B1 6g;Triamcinolone acetonide 40mg;Carbamide ointment 10g;Book on Chinese herbal medicine is antibacterial
Cream 30g;Chlorpheniramine 10g;Chloramphenicol original powder 5g;Metronidazole 8g;B6 ointment 10g;Terbinafine hydrochloride emulsifiable paste 15g;Ketoconazole breast
Cream 10g.
According to the dermopathic external-applied ointment for the treatment of that above-mentioned technical proposal is provided, the pharmacological action of each medicine in its medicine composition
It is described below:
Radonil:Treatment bacterial infection;
Chloramphenicol:Various severe infections caused by treatment sensitive bacterial;
Prednisone:With anti-inflammatory and anti-allergic effects, the hyperplasia of connective tissue, reduction capillary wall and cell membrane can be suppressed
Permeability.Reduction is acute to ooze out, and alleviates inflammatory reaction;
Borneol:For the disease of various pruituses, there is calm anti-inflammatory;
Sofril:It is anti-dandruff, have it is antipruritic, kill bacterium, fungi, mould, acarid, parasite the effects such as, it can also be used to sore, carbuncle and painful swelling;
Vitamin E:Pachylosis can be controlled, is chapped, the treatment to chronic dermatosis reduces pigment deposition to reducing abnormal pigmentary deposit on the skin trace and anti-inflammatory
Have certain effect;
Vitamin is combined B:There is certain curative effect to dermatitis and eczema, treat pachylosis;
VC:Melanin can be suppressed to produce, reduce melanin, for pigmentation spots after inflammation and desalination freckle, reduce skin effect
Perception is effective to various quick dermatoses, such as dermatitis, eczema, drug rash;
Vitamin B1:Other medicines are coordinated to strengthen the curative effect of anti-inflammatory anti-itch;
Chlorpheniramine:Suitable for various allergic to dermatitis, eczema pruitus, neurodermatitis has obvious curative effects;
Metronidazole:Treatment multiple dermatosis, for anaerobic infection treatment, hinder bacterial metabolism, promote bacterial death;
Triamcinolone acetonide:There are inflammation-resisting itch-stopping, antiallergy and pressor effect, it is adaptable to dermatitis and eczema, neurodermatitis, ox-hide
The chronic itch such as tinea, the treatment of anaphylaxis dermatosis;
B6 ointment:Suitable for the various skin diseases such as chapped skin, eczema, acne;
Carbamide ointment:Effect with anti-inflammatory, anti-bacterial, anti-itching, is suitable for rhagadia manus et pedis and chronic inflammation;
The antibacterial cream of book on Chinese herbal medicine:There is bacteriostasis to Escherichia coli, Candida albicans, staphylococcus aureus;
Terbinafine hydrochloride emulsifiable paste:It is fungi-medicine of new generation, with antimycotic effect, there is stronger sterilization to dermatophyte
And bacteriostasis, treat shallow deep mycosis and its fungi in hypodermis infection;
Ketoconazole cream:Suitable for the skin disease of various fungal infections, be mainly used in skin superficial fungal infection, such as tinea of feet and hands,
Ringworm of the body etc..
The present invention embodies above-mentioned each medicine reasonable compatibility to all kinds of dermopathic complex treatment functions, and therapeutic effect is good,
Treatment cost is low.
Dermopathic curative effect is treated to illustrate the invention, and following clinical treatment data is now provided:
(1)Clinical data:Observation case totally 285, man 140, female 145, age 1-70 year, the course of disease -10 years 7 days, wherein
The course of disease less than 15 days 200, -1 year 15 days 55, -10 years 1 year 30, be randomly divided into treatment group 145 and control group 140.
(2)Treatment method:
Treatment group with medicinal ointment therapy of the present invention, substantially just:Radonil 8g, chloramphenicol 7g, prednisone 5g, borneol 4g, sofril 3g,
Vitamin E 5g, vitamin is combined B8g, VC8g, B1 6g, Triamcinolone acetonide 40mg, carbamide ointment 10g, herbal antibacterial cream(River
Xi Bangrui bio tech ltd product, trade name:Busy bee)30g, chlorpheniramine 10g, chloramphenicol original powder 5g, metronidazole
8g, B6 ointment 10g, Terbinafine hydrochloride emulsifiable paste(Main Ingredients and Appearance 0.01g)15g, ketoconazole cream(Main Ingredients and Appearance 10mg)10g;
Each medicine mixing will adjust equal above, be prepared into cream, and twice daily apply and put affected part on the skin, and take this ointment and massage absorption in right amount.
Control group uses clindamycin emulsifiable paste, twice daily.
(3)Criterion of therapeutical effect and treatment results:
Criterion of therapeutical effect is cured:Skin damaged disappears completely;Take a turn for the better:Skin damaged regression more than 50%;Do not heal:Skin damaged regression is less than 5%.
Treatment results:Treatment group and control group Clinical efficacy comparison:It is shown in Table 1.
3.3 bad reactions:Bad reaction table 1, Clinical efficacy comparison example are had no in therapeutic process
Group | n | Cure | Take a turn for the better | Do not heal | Total effective rate(%) |
Treatment group | 145 | 140 | 4 | 1 | 99.31 |
Control group | 140 | 116 | 6 | 18 | 87.14 |
It is described in synthesis, the present invention compared with prior art, with following features:Therapeutic domain is wide, and cure rate is high, treats skin
The diseases such as inflammation, eczema, acne, impetigo, tinea of feet and hands, psoriasis, cure rate is up to 99%.
Specific embodiment
With reference to embodiments and model case the invention will be further described, purpose is only that and more fully understands this
Bright content.Therefore, the cited case is not intended to limit protection scope of the present invention.
Embodiment 1, illness:Dermatitis.
Man, 3 weeks, name:Bi Jiaxuan, address:The Tangshan, Hebei Province Fengnan District willow circle town Xihe River, before the shin of right side, skin damaged
It is just erythema, postemphasis in 3 days, sufferings substantially, are grabbed and may occur in which scratch, are formed a scab, and pachyderma, nothing is oozed out.Using ointment of the present invention:
Radonil 7g, chloramphenicol 6g, prednisone 6g, borneol 3g, sofril 3g, vitamin E 6g, vitamin is combined B5g, VC7g, B1
6g, Triamcinolone acetonide 20mg, carbamide ointment 10g, herbal antibacterial cream(Jiangxi Bang Rui bio tech ltd product)30g, flutters you
Quick 9g, chloramphenicol original powder 5g, metronidazole 7g, B6 ointment 10g;Medicine-feeding is adjusted and is prepared into cream, affected part is twice daily smeared, 7 days
Quan Yu, has no adverse reaction.
Embodiment 2, illness:Acute eczema.
Man, 10 months, Dong Hangyu, address:The Tangshan, Hebei Province Fengnan District Dong Dai village, neck is dispersed in grain grain size papule,
Mound sore rash, water sore, acute pruritus increase have new erosion face to ooze out for 5 days, purulence scab.Using ointment of the present invention:Radonil 6g, chlorine is mould
Plain 5g, prednisone 5g, borneol 3g, sofril 0g vitamin E 5g vitamins are combined B4g, VC6g, B1 5g, Triamcinolone acetonide
10mg, carbamide ointment 10g, herbal antibacterial cream(Jiangxi Bang Rui bio tech ltd product)30g, chlorpheniramine 8g, chloramphenicol
Former powder 4g, metronidazole 6g, B6 ointment 10g;Medicine-feeding is adjusted and is prepared into cream, twice daily smear affected part, 10 days entirely more, without bad
Reaction.
Embodiment 3, illness:Chronic eczema.
Li Shengcai, man, 58 years old, address:Fengnan District willow circle, hand skin is plump, rough surface, March, feels obvious scabies
Itch, in Chen Faxing, gently weigh sometimes sometimes, using ointment of the present invention:Radonil 9g;Chloramphenicol 8g, prednisone 8g, borneol 5g, sulphur
Bloom 8g, vitamin E 8g, vitamin is combined B8g, VC10g, B1 7g, Triamcinolone acetonide 40mg, carbamide ointment 10g, and book on Chinese herbal medicine is antibacterial
Cream(Jiangxi Bang Rui bio tech ltd product)30g, chlorpheniramine 10g, chloramphenicol original powder 8g, metronidazole 10g, B6 ointment
10g;Medicine-feeding is adjusted and is prepared into cream, twice daily smear affected part, entirely more, had no adverse reaction within 25 days.
Embodiment 4, illness:Eczema.
Li Yuxuan, female, 13 years old, there be the papule and mound sore rash being dispersed in Tangshan, Hebei Province Guye District, foot, and oozed out substantially,
Conscious itch.Using ointment of the present invention:Radonil 8g, chloramphenicol 7g, prednisone 5g, borneol 4g, sofril 3g, vitamin E 5g,
Vitamin is combined B8g, VC8g, B1 6g, Triamcinolone acetonide 40mg, carbamide ointment 10g, herbal antibacterial cream(The auspicious biotechnology of Jiangxi nation
Co., Ltd's product)30g, chlorpheniramine 10g, chloramphenicol original powder 5g, metronidazole 8g, B6 ointment 10g;Medicine-feeding is adjusted and is prepared into
Cream, twice daily smears affected part, entirely more, has no adverse reaction within 10 days.
Embodiment 5, illness:Acne.
Wang Jian, man, 20 years old, address:Tangshan Nan Bao development zones, there is the papilla being dispersed on facial inflamed papules, top, there is knot
Section, tumour, when have itch, be in a bad way, ill 2 years Jing are treated without obvious curative effects, come to go to a doctor.Using ointment of the present invention:Newly
The bright 9g of promise, chloramphenicol 8g, prednisone 8g, borneol 5g, sofril 8g, vitamin E 8g, vitamin is combined B8g, VC10g, B1
10g, Triamcinolone acetonide 20mg, carbamide ointment 10g, herbal antibacterial cream(Jiangxi Bang Rui bio tech ltd product)30g, flutters
You are quick 10g, chloramphenicol original powder 8g, metronidazole 10g, B6 ointment 10g;Medicine-feeding is adjusted and is prepared into cream, it is secondary for one that this prepares ointment,
Affected part is twice daily smeared, 6 pairs are complete more, have no adverse reaction.
Embodiment 6, illness:Psoriasis vulgaris.
Lv Baoshun, man, 64 years old, address:The Tangshan City Fengnan District Xinhe River village, Jing treatments in ill 7 years are again and again not apparent from
Turn to come to go to a doctor, patient's four limbs trunk has erythema significantly not of uniform size, around there is inflammatory blush, slightly thickens, and surface is covered
The lid multilayer silvery white scales of skin that peel off feels itch, and the scales of skin that peel off flies one after another in broken foam when scratching, and exposes red smooth basal plane, and peelling off film can
See petechial hemorrhage.Using ointment of the present invention:Radonil 8g, chloramphenicol 7g, prednisone 5g, borneol 4g, sofril 3g, vitamin
E5g, vitamin is combined B8g, VC8g, B1 6g, Triamcinolone acetonide 40mg, carbamide ointment 10g, herbal antibacterial cream(Jiangxi nation
Auspicious bio tech ltd's product)30g, chlorpheniramine 10g, chloramphenicol original powder 5g, metronidazole 8g, B6 ointment 10g, hydrochloric acid is special
Than naphthalene sweet smell emulsifiable paste 15g(Main Ingredients and Appearance 0.01g), ketoconazole cream 10g(Main Ingredients and Appearance 10mg);Medicine-feeding is adjusted and is prepared into cream,
It is secondary for one that this prepares ointment, twice daily smears affected part, and 10 pairs are complete more, have no adverse reaction.
Above-described embodiment is only to explanation for example of the invention.Those skilled in the art can be right
Described specific embodiment is made various modifications or supplements or substituted using similar mode, but without departing from this
Bright spirit surmounts scope defined in appended claims.
Claims (2)
1. one kind treats dermopathic external-applied ointment, it is characterised in that count by weight, by agents hybrid modulation into
Cream:Radonil 6-9 parts;Chloramphenicol 5-8 parts;Prednisone 5-8 parts;Borneol 3-5 parts;Sofril 0-8 parts;Vitamin E 5-8 parts;Dimension
Raw element is combined B 4-8 parts;VC 6-10 parts;B1 5-7 parts;Triamcinolone acetonide 0.01-0.04 parts;10 parts of carbamide ointment;Book on Chinese herbal medicine is antibacterial
30 parts of cream;Chlorpheniramine 8-10 parts;Chloramphenicol original powder 4-8 parts;Metronidazole 6-10 parts;10 parts of B6 ointment;Terbinafine hydrochloride emulsifiable paste
0-15 parts;Ketoconazole cream 0-10 part.
2. one kind according to claim 1 treats dermopathic external-applied ointment, it is characterised in that adjusted by agents mixing
Make cream:Radonil 8g;Chloramphenicol 7g;Prednisone 5g;Borneol 4g;Sofril 5g;Vitamin E 5g;The compound B 8g of vitamin;VC
8g;B1 6g;Triamcinolone acetonide 40mg;Carbamide ointment 10g;The antibacterial cream 30g of book on Chinese herbal medicine;Chlorpheniramine 10g;Chloramphenicol original powder 5g;Metronidazole
8g;B6 ointment 10g;Terbinafine hydrochloride emulsifiable paste 15g;Ketoconazole cream 10g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610907215.0A CN106668864A (en) | 2016-10-19 | 2016-10-19 | External-use ointment for treatment of dermatopathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610907215.0A CN106668864A (en) | 2016-10-19 | 2016-10-19 | External-use ointment for treatment of dermatopathy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106668864A true CN106668864A (en) | 2017-05-17 |
Family
ID=58840023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610907215.0A Pending CN106668864A (en) | 2016-10-19 | 2016-10-19 | External-use ointment for treatment of dermatopathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106668864A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109010344A (en) * | 2018-10-17 | 2018-12-18 | 昆明医科大学第二附属医院 | A kind of preparation for treating impetigo |
CN110638835A (en) * | 2019-10-24 | 2020-01-03 | 李生林 | External ointment for skin and preparation method thereof |
CN110664642A (en) * | 2019-10-24 | 2020-01-10 | 吉开平 | Beautifying cream capable of diminishing inflammation, removing acnes and beautifying face as well as preparation method and application of beautifying cream |
CN111096981A (en) * | 2020-03-02 | 2020-05-05 | 乌力吉白尔 | External-use medicine for treating various skin diseases and its preparing method |
CN113456668A (en) * | 2021-05-27 | 2021-10-01 | 齐万琴 | External ointment for women and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679605A (en) * | 2005-01-11 | 2005-10-12 | 倪明芝 | Medicine for treating refractory ringworm |
-
2016
- 2016-10-19 CN CN201610907215.0A patent/CN106668864A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679605A (en) * | 2005-01-11 | 2005-10-12 | 倪明芝 | Medicine for treating refractory ringworm |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109010344A (en) * | 2018-10-17 | 2018-12-18 | 昆明医科大学第二附属医院 | A kind of preparation for treating impetigo |
CN110638835A (en) * | 2019-10-24 | 2020-01-03 | 李生林 | External ointment for skin and preparation method thereof |
CN110664642A (en) * | 2019-10-24 | 2020-01-10 | 吉开平 | Beautifying cream capable of diminishing inflammation, removing acnes and beautifying face as well as preparation method and application of beautifying cream |
CN111096981A (en) * | 2020-03-02 | 2020-05-05 | 乌力吉白尔 | External-use medicine for treating various skin diseases and its preparing method |
CN113456668A (en) * | 2021-05-27 | 2021-10-01 | 齐万琴 | External ointment for women and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106668864A (en) | External-use ointment for treatment of dermatopathy | |
CN104095999B (en) | A kind of ozonisation Borneolum Syntheticum Oleum Camelliae | |
US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
CN105107007B (en) | A kind of medical protective dressing of cation and preparation method thereof | |
EA032439B1 (en) | Compositions and methods for treating surface wounds | |
EP3164139B1 (en) | Topical compositions and methods for treating wounds | |
CN104056257B (en) | A kind of acne treatment emulsifiable paste | |
CN106176603B (en) | A kind of plants essential oil micro emulsion gel and its preparation method and application | |
CN101843637A (en) | External spray for preventing and treating beriberi and preparation method | |
CN106267329B (en) | A kind of plants essential oil gel dressing and its preparation method and application | |
CN106511478A (en) | Compound essential oil for treating dog tinea as well as preparation method and applications of compound essential oil | |
CN1433781A (en) | Wanli ointment | |
CN106236835A (en) | A kind of plants essential oil spray and its preparation method and application | |
CN107596355A (en) | A kind of Medical pain easing, the exterior-applied gel subsided a swelling, brought down a fever and preparation method thereof | |
CN107158051A (en) | Tannic acid ointment for treating eczema and preparation method thereof | |
CN105726564A (en) | Ointment for treating skin tinea | |
CN105232993A (en) | Natural plant essential oil wound healing ointment and preparation method thereof | |
KR20030037243A (en) | Fiber with biological material and its manufacturing method | |
CN106806268A (en) | A kind of organic prickly-heat powder of baby | |
CN104815103A (en) | Toxin removal powder | |
CN109846847B (en) | Effervescent tablet for treating animal dermatosis and preparation method thereof | |
CN107050049A (en) | A kind of external application bactericide for treating deep fungal dermatoses | |
Ishchenko | Efficiency of apitherapy in practice of veterinary medicine | |
CN1124849C (en) | Nail health disinfecting liquid | |
SODHI | MRSA and Ayurvedic Medicine. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170517 |
|
RJ01 | Rejection of invention patent application after publication |